Source link : https://newshealth.biz/health-news/fda-probes-rsv-drug-safety-why-some-cancers-shouldnt-be-treated-new-mpox-strain/

(MedPage Today) — Note that some links may require registration or subscription. The FDA reportedly told drugmakers that approved monoclonal antibodies to protect infants against respiratory syncytial virus (RSV) would be subject to new safety… Source link : https://www.medpagetoday.com/pediatrics/rsv/118903 Author : Publish date : 2025-12-09 14:32:00 Copyright for syndicated content belongs to the linked Source.

The post FDA Probes RSV Drug Safety; Why Some Cancers Shouldn’t Be Treated; New Mpox Strain first appeared on News Health.

—-

Author : News Health

Publish date : 2025-12-09 14:32:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678